Human Gene MIR1228 (ENST00000408438.1) from GENCODE V44
  Description: Homo sapiens microRNA 1228 (MIR1228), microRNA. (from RefSeq NR_031597)
RefSeq Summary (NR_031597): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000408438.1
Gencode Gene: ENSG00000221365.1
Transcript (Including UTRs)
   Position: hg38 chr12:57,194,504-57,194,576 Size: 73 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 09:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr12:57,194,504-57,194,576)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerGencodeHGNCLynxPubMed

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  LF208941 - JP 2014500723-A/16444: Polycomb-Associated Non-Coding RNAs.
MA444518 - JP 2018138019-A/16444: Polycomb-Associated Non-Coding RNAs.
LF208939 - JP 2014500723-A/16442: Polycomb-Associated Non-Coding RNAs.
MA444516 - JP 2018138019-A/16442: Polycomb-Associated Non-Coding RNAs.
HI965553 - Sequence 838 from Patent WO2010139812.
HI966468 - Sequence 788 from Patent WO2010139811.
HI967334 - Sequence 788 from Patent WO2010139810.
HV594779 - JP 2010539959-A/160: Micromirs.
HV953897 - JP 2012518421-A/809: METHODS OF DETECTING LUNG CANCER.
HW798905 - WO 2014192907-A/11: Method for detecting miRNA used for differentiating disorders causing motor neuropathy.
HZ074651 - JP 2013535982-A/742: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083263 - JP 2015513906-A/620: Stem Cell Microparticles.
HZ157336 - JP 2015130862-A/160: Micromirs.
HZ437044 - JP 2015529450-A/620: Stem Cell Microparticles.
HZ460661 - WO 2015190584-A/158: Kit or device and method for detecting prostate cancer.
HZ461988 - WO 2015190591-A/143: Kit and method for detecting breast cancer.
HZ463695 - WO 2015194610-A/131: Kit and method for detecting lung cancer.
HZ464275 - WO 2015194615-A/93: Kit or device and method for detecting hepatic cancer.
HZ479661 - JP 2015535430-A/167: TERMINALLY MODIFIED RNA.
HZ789592 - JP 2016504050-A/1337: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA032538 - Sequence 11 from Patent WO2011001086.
JA401591 - Sequence 838 from Patent WO2011080318.
JA402569 - Sequence 838 from Patent WO2011080315.
JA403576 - Sequence 838 from Patent WO2011080316.
JA406207 - Sequence 838 from Patent EP2336353.
JA429733 - Sequence 838 from Patent WO2011095623.
JA715027 - Sequence 809 from Patent EP2401406.
JA791846 - Sequence 248 from Patent WO2012089772.
JB022543 - Sequence 385 from Patent WO2013026685.
JB023171 - Sequence 425 from Patent WO2013026684.
JB050161 - Sequence 248 from Patent WO2013020926.
JB074770 - Sequence 30 from Patent WO2012168448.
JB175301 - Sequence 333 from Patent WO2012101219.
JB620836 - Sequence 816 from Patent WO2013063544.
JC172248 - Sequence 620 from Patent WO2013150303.
JC512324 - Sequence 2577 from Patent WO2014113089.
JC573059 - Sequence 620 from Patent WO2014125276.
JC582747 - Sequence 620 from Patent WO2014125277.
JE954443 - Sequence 620 from Patent WO2015052526.
JE956196 - Sequence 620 from Patent WO2015052527.
LF137948 - JP 2016507550-A/620: Method of Producing Microparticles.
LF161615 - JP 2016513950-A/1681: Oligomers with improved off-target profile.
LF162913 - JP 2016513095-A/620: Stem Cell Microparticles and miRNA.
LF632664 - WO 2016117582-A/93: miRNA biomarkers for mental disorders.
LF644482 - JP 2016144439-A/73: Method for assessing cell aging.
LF953665 - JP 2016534103-A/620: Stem Cell Microparticles and miRNA.
LG006010 - KR 1020150004822-A/620: STEM CELL MICROPARTICLES.
LG053706 - KR 1020150059168-A/620: STEM CELL MICROPARTICLES.
LG240945 - KR 1020160035087-A/620: STEM CELL MICROPARTICLES AND MIRNA.
LP643871 - Sequence 29 from Patent WO2015091892.
LP727094 - Sequence 788 from Patent EP2883966.
LP819364 - Sequence 788 from Patent EP3296406.
LP895656 - Sequence 520 from Patent EP3253886.
LP939306 - Sequence 788 from Patent EP3184651.
LQ069912 - Sequence 236 from Patent EP2964234.
LQ278630 - Sequence 169 from Patent WO2016066288.
LQ441023 - Sequence 30 from Patent EP3029157.
LQ564997 - Sequence 22 from Patent WO2016139092.
LQ930993 - Sequence 7 from Patent WO2014187884.
LV471030 - JP 2016534036-A/620: Stem Cell Microparticles and miRNA.
LY404844 - KR 1020160117535-A/149: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY497596 - KR 1020170018409-A/131: KIT OR DEVICE FOR DETECTING LUNG CANCER, AND LUNG CANCER DETECTION METHOD.
LY498176 - KR 1020170018411-A/93: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498991 - KR 1020170018412-A/143: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500534 - KR 1020170016490-A/158: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238365 - WO 2017171048-A/26: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MA260083 - JP 2017505623-A/149: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA406144 - WO 2018155427-A/918: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA643413 - JP 2017113010-A/1337: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731297 - JP 2017140048-A/167: TERMINALLY MODIFIED RNA.
MP014993 - Sequence 196 from Patent WO2019016252.
MS673622 - Sequence 425 from Patent EP3135774.
MS834692 - Sequence 838 from Patent EP3112479.
MS869453 - Sequence 158 from Patent EP3156483.
MS880306 - Sequence 143 from Patent EP3156498.
MS901912 - Sequence 385 from Patent EP3156505.
MS996662 - Sequence 131 from Patent EP3159416.
HZ461051 - WO 2015190584-A/548: Kit or device and method for detecting prostate cancer.
HZ462552 - WO 2015190591-A/707: Kit and method for detecting breast cancer.
HZ464059 - WO 2015194610-A/495: Kit and method for detecting lung cancer.
HZ464720 - WO 2015194615-A/538: Kit or device and method for detecting hepatic cancer.
LY497960 - KR 1020170018409-A/495: KIT OR DEVICE FOR DETECTING LUNG CANCER, AND LUNG CANCER DETECTION METHOD.
LY498621 - KR 1020170018411-A/538: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499555 - KR 1020170018412-A/707: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500924 - KR 1020170016490-A/548: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238882 - WO 2017171048-A/543: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869843 - Sequence 548 from Patent EP3156483.
MS880870 - Sequence 707 from Patent EP3156498.
MS997026 - Sequence 495 from Patent EP3159416.
HZ408827 - JP 2015528002-A/1424: CHIRAL CONTROL.
HZ459484 - WO 2015182781-A/187: Kit or device and method for detecting pancreatic cancer.
HZ460221 - WO 2015190542-A/227: Kit or device and method for detecting biliary tract cancer.
HZ460847 - WO 2015190584-A/344: Kit or device and method for detecting prostate cancer.
HZ461412 - WO 2015190586-A/225: Kit and method for detecting colon cancer.
HZ462266 - WO 2015190591-A/421: Kit and method for detecting breast cancer.
HZ463164 - WO 2015194535-A/258: Kit and method for detecting stomach cancer.
HZ463875 - WO 2015194610-A/311: Kit and method for detecting lung cancer.
HZ464498 - WO 2015194615-A/316: Kit or device and method for detecting hepatic cancer.
HZ465238 - WO 2015194627-A/291: Kit and method for detecting esophageal cancer.
LG052161 - KR 1020150036642-A/1427: CHIRAL CONTROL.
LY480924 - KR 1020170010856-A/187: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495848 - KR 1020170015509-A/227: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496421 - KR 1020170018406-A/291: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497055 - KR 1020170016485-A/225: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497776 - KR 1020170018409-A/311: KIT OR DEVICE FOR DETECTING LUNG CANCER, AND LUNG CANCER DETECTION METHOD.
LY498399 - KR 1020170018411-A/316: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499269 - KR 1020170018412-A/421: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY499977 - KR 1020170019425-A/258: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500720 - KR 1020170016490-A/344: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238615 - WO 2017171048-A/276: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
LZ238796 - WO 2017171048-A/457: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869013 - Sequence 227 from Patent EP3156500.
MS869639 - Sequence 344 from Patent EP3156483.
MS880584 - Sequence 421 from Patent EP3156498.
MS884242 - Sequence 225 from Patent EP3156499.
MS885096 - Sequence 258 from Patent EP3156503.
MS994429 - Sequence 291 from Patent EP3159406.
MS996842 - Sequence 311 from Patent EP3159416.
HZ459589 - WO 2015182781-A/292: Kit or device and method for detecting pancreatic cancer.
HZ460370 - WO 2015190542-A/376: Kit or device and method for detecting biliary tract cancer.
HZ461599 - WO 2015190586-A/412: Kit and method for detecting colon cancer.
HZ463359 - WO 2015194535-A/453: Kit and method for detecting stomach cancer.
HZ464163 - WO 2015194610-A/599: Kit and method for detecting lung cancer.
HZ464816 - WO 2015194615-A/634: Kit or device and method for detecting hepatic cancer.
HZ465437 - WO 2015194627-A/490: Kit and method for detecting esophageal cancer.
LY481029 - KR 1020170010856-A/292: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495997 - KR 1020170015509-A/376: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496620 - KR 1020170018406-A/490: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497242 - KR 1020170016485-A/412: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498064 - KR 1020170018409-A/599: KIT OR DEVICE FOR DETECTING LUNG CANCER, AND LUNG CANCER DETECTION METHOD.
LY498717 - KR 1020170018411-A/634: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500172 - KR 1020170019425-A/453: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ239080 - WO 2017171048-A/741: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869162 - Sequence 376 from Patent EP3156500.
MS884429 - Sequence 412 from Patent EP3156499.
MS885291 - Sequence 453 from Patent EP3156503.
MS994628 - Sequence 490 from Patent EP3159406.
MS997130 - Sequence 599 from Patent EP3159416.
HI965554 - Sequence 839 from Patent WO2010139812.
HI966498 - Sequence 818 from Patent WO2010139811.
HI967364 - Sequence 818 from Patent WO2010139810.
HV594778 - JP 2010539959-A/159: Micromirs.
HV749993 - WO 2012063894-A/15: A composition comprising an antisense oligonucleotide of miRNA.
HW043345 - WO 2012147800-A/13: Composition and Method for Predicting Treatment Sensitivity to Trastuzumab in Patient with Breast Cancer.
HW122396 - JP 2013504331-A/55: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
HW670992 - JP 2013538583-A/8: MARKER CONSISTING OF PLASMA MICRORNA AND A NEW METHOD FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA.
HZ074652 - JP 2013535982-A/743: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157335 - JP 2015130862-A/159: Micromirs.
HZ459361 - WO 2015182781-A/64: Kit or device and method for detecting pancreatic cancer.
HZ460071 - WO 2015190542-A/77: Kit or device and method for detecting biliary tract cancer.
HZ461217 - WO 2015190586-A/30: Kit and method for detecting colon cancer.
HZ462965 - WO 2015194535-A/59: Kit and method for detecting stomach cancer.
HZ464130 - WO 2015194610-A/566: Kit and method for detecting lung cancer.
HZ464353 - WO 2015194615-A/171: Kit or device and method for detecting hepatic cancer.
HZ465023 - WO 2015194627-A/76: Kit and method for detecting esophageal cancer.
HZ479660 - JP 2015535430-A/166: TERMINALLY MODIFIED RNA.
HZ789591 - JP 2016504050-A/1336: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401592 - Sequence 839 from Patent WO2011080318.
JA402570 - Sequence 839 from Patent WO2011080315.
JA403577 - Sequence 839 from Patent WO2011080316.
JA406208 - Sequence 839 from Patent EP2336353.
JA429734 - Sequence 839 from Patent WO2011095623.
JA792159 - Sequence 208 from Patent WO2012089753.
JB249331 - Sequence 99 from Patent EP2478360.
JB361509 - Sequence 8 from Patent EP2596136.
JB620837 - Sequence 817 from Patent WO2013063544.
JC030416 - Sequence 15 from Patent EP2638912.
JC480472 - Sequence 13 from Patent EP2703488.
JC512323 - Sequence 2576 from Patent WO2014113089.
JE844286 - Sequence 29 from Patent WO2015091897.
JE867334 - Sequence 141 from Patent WO2015128671.
LF160273 - JP 2016513950-A/339: Oligomers with improved off-target profile.
LF632592 - WO 2016117582-A/21: miRNA biomarkers for mental disorders.
LF636371 - JP 2016519076-A/145: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LG134528 - KR 1020150131312-A/146: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LP643844 - Sequence 2 from Patent WO2015091892.
LP727124 - Sequence 818 from Patent EP2883966.
LP819394 - Sequence 818 from Patent EP3296406.
LP939336 - Sequence 818 from Patent EP3184651.
LP951929 - Sequence 435 from Patent WO2017157650.
LQ069911 - Sequence 235 from Patent EP2964234.
LQ278727 - Sequence 266 from Patent WO2016066288.
LQ724813 - Sequence 446 from Patent WO2018096084.
LX154493 - JP 2017509333-A/141: Biomarkers for Endometriosis.
LX280768 - JP 2016105097-A/55: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LY404843 - KR 1020160117535-A/148: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY480801 - KR 1020170010856-A/64: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495698 - KR 1020170015509-A/77: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496206 - KR 1020170018406-A/76: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY496860 - KR 1020170016485-A/30: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498031 - KR 1020170018409-A/566: KIT OR DEVICE FOR DETECTING LUNG CANCER, AND LUNG CANCER DETECTION METHOD.
LY498254 - KR 1020170018411-A/171: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499778 - KR 1020170019425-A/59: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ234386 - JP 2017181518-A/55: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LZ238537 - WO 2017171048-A/198: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MA260082 - JP 2017505623-A/148: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA406183 - WO 2018155427-A/957: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA643412 - JP 2017113010-A/1336: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731296 - JP 2017140048-A/166: TERMINALLY MODIFIED RNA.
MS834693 - Sequence 839 from Patent EP3112479.
MS868863 - Sequence 77 from Patent EP3156500.
MS884047 - Sequence 30 from Patent EP3156499.
MS884897 - Sequence 59 from Patent EP3156503.
MS994214 - Sequence 76 from Patent EP3159406.
MS997097 - Sequence 566 from Patent EP3159416.
MA800466 - JP 2018183181-A/1337: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA805743 - WO 2018199275-A/3: Kit, device and method for detection of ovary tumor.
MA806289 - WO 2018199275-A/549: Kit, device and method for detection of ovary tumor.
MA806018 - WO 2018199275-A/278: Kit, device and method for detection of ovary tumor.
MA806360 - WO 2018199275-A/620: Kit, device and method for detection of ovary tumor.
MA800465 - JP 2018183181-A/1336: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA805813 - WO 2018199275-A/73: Kit, device and method for detection of ovary tumor.
MA822362 - WO 2019004436-A/175: Kit, device, and method for detection of lung cancer.
MP129720 - Sequence 620 from Patent EP3470073.
MP162643 - Sequence 620 from Patent WO2019069093.
MA823006 - WO 2019004436-A/819: Kit, device, and method for detection of lung cancer.
MA822698 - WO 2019004436-A/511: Kit, device, and method for detection of lung cancer.
MA823159 - WO 2019004436-A/972: Kit, device, and method for detection of lung cancer.
MA822494 - WO 2019004436-A/307: Kit, device, and method for detection of lung cancer.
MB017890 - JP 2018506997-A/22: SIGNATURE OF HEALTH.
MB021441 - JP 2019050772-A/12: A test method for predicting side reactions after vaccination.
LY616129 - KR 1020180129785-A/26: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616646 - KR 1020180129785-A/543: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616379 - KR 1020180129785-A/276: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616560 - KR 1020180129785-A/457: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616844 - KR 1020180129785-A/741: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616301 - KR 1020180129785-A/198: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
MB407850 - WO 2019159884-A/1340: Kit, device, and method for detection of dementia.
MB407924 - WO 2019159884-A/1414: Kit, device, and method for detection of dementia.
MB407893 - WO 2019159884-A/1383: Kit, device, and method for detection of dementia.
MB420705 - JP 2019154320-A/73: Method for evaluating cell quality.
MB472610 - WO 2019208671-A/9: Kit or device and method for detecting bladder cancer.
MB473112 - WO 2019208671-A/511: Kit or device and method for detecting bladder cancer.
MB472852 - WO 2019208671-A/251: Kit or device and method for detecting bladder cancer.
MB472853 - WO 2019208671-A/252: Kit or device and method for detecting bladder cancer.
MB473111 - WO 2019208671-A/510: Kit or device and method for detecting bladder cancer.
MB472609 - WO 2019208671-A/8: Kit or device and method for detecting bladder cancer.
MC003353 - WO 2020032228-A/8: Kit and method for detecting prostate cancer.
MC003377 - WO 2020032228-A/32: Kit and method for detecting prostate cancer.
MC003362 - WO 2020032228-A/17: Kit and method for detecting prostate cancer.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_031597, uc021qzh.1
UCSC ID: ENST00000408438.1
RefSeq Accession: NR_031597

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.